Dr. Paul Chapman on the Choice to Pursue Adjuvant Immunotherapy for Melanoma Patients

Cancer Network spoke with Paul B. Chapman, MD, of Memorial Sloan Kettering Cancer Center, about pursuing adjuvant immunotherapy for patients with melanoma.

Source: CancerNetwork - June 19, 2019 Category: Cancer & Oncology Authors: Paul B. Chapman, MD Source Type: news